Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

12

Revenue 2017

Bayer

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bayer's 2013 sales performance.

Bayer

EMA clears Novo Nordisk’s long-acting haemophilia A drug

EMA clears Novo Nordisk’s long-acting haemophilia A drug Takeda’s Shire unit already has a long-acting factor VIII product on the market in Adynovate, as does Sanofi with Eloctate from its recent Bioverativ acquisition, Bayer with Kovaltry, and

Mistrust of pharma still blocking NHS collaborations

Mistrust of pharma still blocking NHS collaborations treatments from Novartis and Bayer.

England to fast-track tumour agnostic drugs like Vitrakvi – if the price is right

England to fast-track tumour agnostic drugs like Vitrakvi – if the price is right Stevens referenced two of these novel therapies – Bayer/Loxo’s Vitrakvi(larotrectinib) and Roche’s entrectinib – even though neither of these drugs are yet approved in Europe. ... Bayer/Loxo’s Vitrakvi is expected to gain CHMP recommendation in

Celgene says no to Mereo’s cancer drug etigilimab

Celgene says no to Mereo’s cancer drug etigilimab GlaxoSmithKline-partnered tarextumab for pancreatic cancer was the first casualty in 2016, followed by Celgene-partnered demicizumab a year later, and then Bayer pulled out of its alliance.

Roche’s Polivy gets FDA okay for lymphoma chemo-immunotherapy

Roche’s Polivy gets FDA okay for lymphoma chemo-immunotherapy Polivy is one of two new cancer approvals Roche is anticipating this year along with entrectinib for NTRK fusion-positive solid tumours, a rival to Bayer/Loxo’s recently-approved Vitrakvi

[ Previous 5 results ] 8 9 10 11 12 13 14 15 16 17 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Happy Chinese New Year 2020 - The Year of The Rat
A fond farewell to The Year of the Pig...
White Paper for download - Explaining the price of your product
In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...

Infographics